🇸🇬 Imlygic in Singapore

Imlygic (TALIMOGENE LAHERPAREPVEC) regulatory status in Singapore.

Marketing authorisation

HSA

  • Status: likely_approved

Imlygic in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Oncology approved in Singapore

Frequently asked questions

Is Imlygic approved in Singapore?

Yes. HSA has authorised it.

Who is the marketing authorisation holder for Imlygic in Singapore?

Amgen is the originator. The local marketing authorisation holder may differ — check the official source linked above.